Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/28516| Title: | ADE and dengue vaccination |
| Authors: | MARTINEZ-VEGA, Ruth Arali; CARRASQUILA, Gabriel; LUNA, Expedito; RAMOS-CASTANEDA, Jose |
| Citation: | VACCINE, v.35, n.32, p.3910-3912, 2017 |
| Abstract: | The vaccine against Dengue virus (DENY), Dengvaxia (R) (CYD), produced by Sanofi-Pasteur, has been registered by several national regulatory agencies; nevertheless, the performance and security of this vaccine have been challenged in a series of recent papers. In this work, we intend to contribute to the debate by analyzing the concept of an enhancing vaccine, presenting objections to the epidemiological model base of the concept and, likewise, presenting data that contradict that concept. |
| Appears in Collections: | Artigos e Materiais de Revistas Científicas - IMT Artigos e Materiais de Revistas Científicas - LIM/52 Artigos e Materiais de Revistas Científicas - ODS/03 |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| art_MARTINEZ-VEGA_ADE_and_dengue_vaccination_2017.PDF Restricted Access | publishedVersion (English) | 245.12 kB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.